CLINICAL_TRIALS
research
· 2019-07-31
Clinical Trial Update: An Open-label Study to Evaluate the Long-term Safety of MEDI-546, for the Treatment of SLE, in Adults [Phase 2]
Summary
Open-label Phase 2 trial evaluating long-term safety of MEDI-546 for systemic lupus erythematosus (SLE) in adults.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: MedImmune LLC | Conditions: Lupus Erythematosus, Systemic | Phase 2 | Status: COMPLETED | Results posted: 2019-07-31